Hereditary Angioedema - 9 Studies Found

Completed : C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
: Hereditary Angioedema
: 2006-02-07
:
  • Biological: C1 esterase inhibitor [human] (C1INH-nf)
Completed : A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor
: Hereditary Angioedema Types I and II
: 2012-12-24
:
  • Biological: Berinert Berinert

Completed : A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
: Hereditary Angioedema Types I and II
: 2012-04-10
:
  • Biological: C1-esterase inhibitor - single intravenous dose

Completed : Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
: Hereditary Angioedema Types I and II
: 2011-11-07
: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection
Completed : Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
:
  • Hereditary Angioedema Type I
  • Angioneurotic Edema

: 2005-07-04
: Drug: C1 inhibitor concentrate
RECRUITING : CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema
: Hereditary Angioedema (HAE)
: 2024-11-21
: Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC)
RECRUITING : A Study of STAR-0215 in Participants With Hereditary Angioedema
: Hereditary Angioedema
: 2024-11-21
: STAR-0215 will be administered as a subcutaneous bolus injection.
COMPLETED : A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home
: Hereditary Angioedema (HAE)
: 2024-11-21
: No Intervention will be administered in this study.
COMPLETED : A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II
: Hereditary Angioedema (HAE)
: 2024-11-21